药物发现
限制
计算机科学
生化工程
数据科学
桥(图论)
风险分析(工程)
生物信息学
工程类
医学
生物
解剖
机械工程
作者
Hai Tao Xue,Michael Stanley-Baker,Adams Wai‐Kin Kong,HY Li,Wilson Wen Bin Goh
标识
DOI:10.1016/j.drudis.2022.05.009
摘要
• Natural products are an important source of therapeutic compounds. • Natural product research can benefit greatly from advances in AI. • Knowledge integration is a limiting step for natural-product-based drug discovery. Natural products (NPs) constitute a large reserve of bioactive compounds useful for drug development. Recent advances in high-throughput technologies facilitate functional analysis of therapeutic effects and NP-based drug discovery. However, the large amount of generated data is complex and difficult to analyze effectively. This limitation is increasingly surmounted by artificial intelligence (AI) techniques but more needs to be done. Here, we present and discuss two crucial issues limiting NP-AI drug discovery: the first is on knowledge and resource development (data integration) to bridge the gap between NPs and functional or therapeutic effects. The second issue is on NP-AI modeling considerations, limitations and challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI